Warren Simangolwa, PhD retweeted
It was a pleasure working with @asteriskmgzn on this piece, which looks at a case study where regulatory reliance works well. Thank you @chengela and @clarabcollier for making the editing process wonderful!
Zambia approved a new HIV drug in just 12 days, far outpacing the average of 4-7 years in sub-Saharan Africa.
How did they do it? Most countries spend years reviewing drug applications that have already been approved by the FDA or EMA. Zambia decided to do things differently, building a system that treated prior approvals from trusted agencies as a starting point.
@EnlliMcA dives into Zambia’s process, and what we can learn from their experience:
Warren Simangolwa, PhD retweeted
If they are to be real compacts, they must become two-way deals. That means defining roles and responsibilities for donors, not just governments. This includes agreements on financing modalities and alignment behind a national plan, cgdev.org/blog/one-sided-com…
Warren Simangolwa, PhD retweeted
Lusaka Agenda proposed a way forward to reform & strengthen @gavi, @GlobalFund & other GHIs. But how will we know if there is progress? In this @CGDev paper @sophie_witter & I offer an independent proposal for a Lusaka Agenda Tracker:
cgdev.org/blog/lusaka-agenda…
Warren Simangolwa, PhD retweeted
It's been 10 years of the international Decision Support Initiative (iDSI). What lessons have we learned? 🏥
@peterbaker17 and @JavierHGuzmanC share six takeaways countries should consider when building institutions for priority setting in health:
bit.ly/3VkADMp
Warren Simangolwa, PhD retweeted
Just published! Huge meta-analysis for 14 interventions for HIV/TB/malaria/syphilis in @LancetGH. Feeling privileged to write a response Comment on how to ensure the data are relevant to policy maker in prioritizing #HBPs @CGDev @LSHTM_GHECO thelancet.com/journals/langl…
Warren Simangolwa, PhD retweeted
The national prevalence of #diabetes in #Ghana is likely to be substantially higher than currently reported considering the subnational prevalence estimates. Check out our review journals.plos.org/globalpubl… @IntDiabetesFed @FrancisJRuizHE @AnnaVassall
Warren Simangolwa, PhD retweeted
Evidence-based priority setting has the potential to address inefficiency in healthcare, but are we being efficient?
🆕 blog from the @idsihealth team ➡️ bit.ly/47gFeDj
Warren Simangolwa, PhD retweeted
I am happy to share this paper published with @ErkuDaniel recently on Institutionalizing health technology assessment in Ethiopia: seizing the window of opportunity bit.ly/3DHqn73 @BCEPShealth @OFNorheim @healtheconomics @getchkid @kchalkidou @asoucat @lia_tadesse @CGDev
Warren Simangolwa, PhD retweeted
"adaptive" HTA (#aHTA) can improve efficiency of any HTA system. Our new #iDSI systematic review + my 1st PhD paper🤓defines aHTA methods in @ISPORJournals (rb.gy/41bje) w/@H7RAL @FrancisJRuizHE @JavierHGuzmanC @AnnaVassall et al . Key points? 🧵
Warren Simangolwa, PhD retweeted
#IHEA2023Congress Flexing HTA to adapt for time, data, & capacity? Join us at 1:30 in 2.44 to discuss “adaptive HTA”. I’ll present our new SR in #ViH on #aHTA methods w/ examples from Brian Asare & @shankarprinja, +@AnnaVassall @FrancisJRuizHE @LiekeHeupink
@CGDev @LSHTM_GHECO
Warren Simangolwa, PhD retweeted
Mathematical proof that applying HTA to investment decisions never leaves you poorer and less healthy! @idsihealth @CGDev Thanks to Alec Morton et al for this excellent analysis - link.springer.com/article/10… presented at #IHEA2023Congress
Warren Simangolwa, PhD retweeted
Eleanor Grieve with HEHTA alumni @mukewarren @UKZN who presented 'Stakeholder perceptions of national health insurance in Zambia' at the #IHEA2023Congress yesterday.
We are so proud of our alumni making a difference in the field of #globalhealth! 🌍🩺
Warren Simangolwa, PhD retweeted
Excited to be here at #IHEA2023Congress in Cape Town.. “if a cost minimization analysis is all that’s needed, we won’t do a full bespoke analysis”- rapid or “adaptive” HTA methods being used by @HE2RO_SA in South Africa. Considerations incl clinical effects, cost, c/e etc #aHTA
Warren Simangolwa, PhD retweeted
Healthcare priority-setting criteria and social values in Iran: an investigation of local evidence | International Journal of Technology Assessment in Health Care | Cambridge Core - bit.ly/46dvNnC
Warren Simangolwa, PhD retweeted
Is It Time to Explore the Health Policy Process Within Governance and Health Systems Frameworks?; Comment on “Modelling the Health Policy Process: One Size Fits All or Horses for Courses?” dlvr.it/Sq4h2l
Warren Simangolwa, PhD retweeted
Thrilled to see 'How Least Developed to Lower-Middle Income Countries Use Health Technology Assessment: A Scoping Review', co-authored by HEHTA staff & alumni, is being featured on the cover of this month's Pathogens and Global Health!
Read➡️tandfonline.com/doi/full/10.…
Warren Simangolwa, PhD retweeted
Putting #Aid in its Place: A New Compact for Financing Cost-Effective #GlobalHealth to Assure Sustainability and Value -new @CGDev Tom Drake, @LydiaRegan @JavierHGuzmanC @peterbaker17 cgdev.org/blog/putting-aid-i…
Warren Simangolwa, PhD retweeted
Pleased to share our latest paper "Pathways to care: IDPs seeking health support and justice for sexual and gender-based violence through social connections in Somalia & Congo" bit.ly/3cVBAHz
Warren Simangolwa, PhD retweeted
👉🏾Sustained high-level commitment, sustainable financing, health system readiness, & institutionalisation are prerequisites for a successful design & implementation of EHSP. @BCEPShealth @DCPThree @DrAlaAlwan @OFNorheim @majdzadehr
Read the detail here👇🏿 gh.bmj.com/content/8/Suppl_1…






















